Brief: Singular Health Says Entered A 50/50 Joint Venture In Macau With A Strategic Investor
24/02/2022 01:30
Feb 24 (Reuters) - Singular Health Group Ltd SHG.AX :
* ENTERED A 50/50 JOINT VENTURE IN MACAU WITH A STRATEGIC
INVESTOR
* JV TO INVESTIGATE MARKET POTENTIAL FOR SCAN TO SURGERY TO
EAST
ASIAN MARKET
Source text for Eikon: ID:nASX2TBYzX
Further company coverage: SHG.AX
Recent news on Singular Health
See all newsBrief: Singular Health Group Receives US$3.0M From State Of Florida For Medical Imaging Data Repository
Brief: Singular Health Announces FDA 510(K) Clearance For 3Dicom MD Cloud
Australia's Singular Health hits two-month high on FDA clearance for medical imaging tech
Brief: Singular Health Signs USD$1.3M Contract With Provider Network Solutions
Brief: Singular Health Seeks Trading Halt